Link between two key Alzheimer’s proteins explained
Researchers at the School of Medicine are getting a clearer picture of the connection between tau and amyloid beta, the two proteins at the heart of Alzheimer’s disease. Their insights may lead to new treatments.
Washington People: Mary Politi
Whether in person or through evidence-based decision tools, the School of Medicine’s Mary Politi, a health psychologist and associate professor of surgery, works with patients to empower them and help optimize their care.
Infectious diseases docs may be lifesaving for patients with antibiotic-resistant infections
For patients with difficult-to-treat, drug-resistant infections, seeing an infectious diseases specialist can be a lifesaver. Such patients experienced significantly lower mortality rates when treated by physicians specializing in infectious diseases, according to a School of Medicine study.
Higher doses of radiation don’t improve survival in prostate cancer
A new study shows that higher doses of radiation do not improve survival for many patients with prostate cancer, compared with the standard radiation treatment. The analysis, which included 104 radiation therapy oncology groups across North America, was led by researchers at the School of Medicine.
Landau memorial service planned April 7
A service celebrating the life of William Landau, MD, professor emeritus of neurology at Washington University School of Medicine in St. Louis, will be at 1 p.m. April 7 in Moore Auditorium on the Medical Campus.
No progress seen in reducing antibiotics among outpatients
Despite public health campaigns aimed at reducing unnecessary prescriptions for antibiotics, the drugs continue to be prescribed at startlingly high rates in outpatient settings such as clinics and physician offices, according to a new School of Medicine study.
Gut microbes influence severity of intestinal parasitic infections
A new School of Medicine study indicates that gut microbes influence the severity of parasitic worm infections in developing countries. The findings suggest that manipulating the gut’s microbial communities may offer protection.
New way to fight sepsis: Rev up patients’ immune systems
A small clinical trial led by Richard S. Hotchkiss, MD, at the School of Medicine, shows that a drug that revs up the immune system holds promise in treating sepsis. The approach goes against the grain of earlier strategies that have relied on antibiotics and inflammatory medications to tamp down the immune system.
Ladenson honored by clinical chemistry society
Jack H. Ladenson, the Oree M. Carroll and Lillian B. Ladenson Professor of Clinical Chemistry in Pathology and Immunology at Washington University School of Medicine in St. Louis, has received the 2017 Distinguished Award for Contributions to Cardiovascular Diagnostics from the International Federation of Clinical Chemistry.
Decoy molecules target E. coli to treat UTIs in mice
School of Medicine researchers report they found a way to treat urinary tract infections without using antibiotics, at least in mice. The scientists are working on an alternative that would prevent bacteria from causing disease.
View More Stories